PolyNovo Limited
ASX: PNV.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bruce Peatey
- Employees
- 282
- Headquarters
- Port Melbourne, Australia
- IPO year
- 1998
- Market cap
- A$697.8M
- Website
- https://polynovo.com
Loading PNV…
Loading profile data…Frequently asked questions about PNV
What does PolyNovo Limited (PNV.AX) do?
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hern...
Where does PNV.AX trade?
PolyNovo Limited (PNV.AX) trades on the Australian Securities Exchange.
What sector is PNV.AX in?
PolyNovo Limited (PNV.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of PolyNovo Limited?
Bruce Peatey is the chief executive officer of PolyNovo Limited (PNV.AX).
Where is PolyNovo Limited headquartered?
PolyNovo Limited is headquartered in Australia.
Does PNV.AX pay a dividend?
PolyNovo Limited (PNV.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PNV.AX go public?
PolyNovo Limited (PNV.AX) completed its initial public offering in 1998.